NXPH4: The Potential Drug Target and Biomarker (G11247)

Target Name: NXPH4

NCBI ID: G11247

NXPH4

NXPH4: The Potential Drug Target and Biomarker

NXPH4 (N-Acetyl-L-Leucine aminotransferase) is a protein that is expressed in various tissues, including muscle, heart, and brain. It is a member of the G protein-coupled receptor (GPCR) family and is involved in the regulation of muscle growth and differentiation, as well as neurotransmitter signaling. NXPH4 has also been shown to play a role in cancer progression and treatment response.

The search for new drug targets and biomarkers has led to the identification of NXPH4 as a potential drug target. NXPH4 has been shown to be involved in a variety of signaling pathways, including the TGF-β pathway, which is involved in cell growth, differentiation, and survival. Additionally, NXPH4 has been shown to be involved in the regulation of the Wnt pathway, which is involved in cell-to-cell signaling and the development of tissues.

Drug Target Potential

The TGF-β pathway is a well-established drug target and a potential target for NXPH4. NXPH4 has been shown to play a role in the regulation of TGF-β signaling in various tissues, including muscle and heart. Studies have shown that NXPH4 can inhibit the activity of the TGF-β receptor, which is involved in the regulation of cell growth and differentiation.

In addition to its role in TGF-β signaling, NXPH4 has also been shown to play a role in the regulation of the Wnt pathway. The Wnt pathway is involved in cell-to-cell signaling and the development of tissues, and has been implicated in the development of various diseases, including cancer. NXPH4 has been shown to be involved in the regulation of Wnt signaling in various tissues and has been shown to play a role in the development of cancer.

Biomarker Potential

NXPH4 has also been shown to be involved in the regulation of various signaling pathways and has the potential to serve as a biomarker for a variety of diseases. For example, NXPH4 has been shown to play a role in the regulation of cell proliferation and has been shown to be involved in the development of various cancers. Additionally, NXPH4 has been shown to play a role in the regulation of neurotransmitter signaling and has been implicated in the development of various neurological disorders.

Conclusion

NXPH4 is a protein that is involved in a variety of signaling pathways and has the potential to serve as a drug target or biomarker for a variety of diseases. Its role in the regulation of TGF-β and Wnt signaling, as well as its involvement in the regulation of cell proliferation and neurotransmitter signaling, make NXPH4 a promising target for future research. Further studies are needed to fully understand the role of NXPH4 in these signaling pathways and its potential as a drug target or biomarker.

Protein Name: Neurexophilin 4

Functions: May be signaling molecules that resemble neuropeptides and that act by binding to alpha-neurexins and possibly other receptors

The "NXPH4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NXPH4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets